Parametric Portfolio Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $7.51M | Sell |
106,973
-4,161
| -4% | -$292K | ﹤0.01% | 1565 |
|
2021
Q4 | $10.7M | Sell |
111,134
-4,441
| -4% | -$428K | 0.01% | 1325 |
|
2021
Q3 | $10M | Buy |
115,575
+29,839
| +35% | +$2.59M | 0.01% | 1353 |
|
2021
Q2 | $7.02M | Sell |
85,736
-5,669
| -6% | -$464K | ﹤0.01% | 1623 |
|
2021
Q1 | $8.69M | Sell |
91,405
-148,061
| -62% | -$14.1M | 0.01% | 1782 |
|
2020
Q4 | $14.9M | Sell |
239,466
-25,343
| -10% | -$1.57M | 0.01% | 1272 |
|
2020
Q3 | $15.7M | Sell |
264,809
-9,889
| -4% | -$588K | 0.01% | 1057 |
|
2020
Q2 | $19.2M | Sell |
274,698
-27,206
| -9% | -$1.9M | 0.01% | 903 |
|
2020
Q1 | $13.7M | Sell |
301,904
-3,153
| -1% | -$143K | 0.01% | 1019 |
|
2019
Q4 | $19.8M | Buy |
305,057
+59,187
| +24% | +$3.85M | 0.01% | 988 |
|
2019
Q3 | $15.3M | Sell |
245,870
-53,402
| -18% | -$3.32M | 0.01% | 1113 |
|
2019
Q2 | $21.3M | Sell |
299,272
-895
| -0.3% | -$63.7K | 0.02% | 889 |
|
2019
Q1 | $23.5M | Buy |
300,167
+75,420
| +34% | +$5.91M | 0.02% | 793 |
|
2018
Q4 | $19M | Sell |
224,747
-56,974
| -20% | -$4.82M | 0.02% | 834 |
|
2018
Q3 | $48.2M | Sell |
281,721
-36,450
| -11% | -$6.24M | 0.04% | 398 |
|
2018
Q2 | $41.1M | Sell |
318,171
-20,445
| -6% | -$2.64M | 0.04% | 438 |
|
2018
Q1 | $34.9M | Buy |
338,616
+40,577
| +14% | +$4.18M | 0.03% | 514 |
|
2017
Q4 | $25.5M | Sell |
298,039
-25,813
| -8% | -$2.2M | 0.03% | 654 |
|
2017
Q3 | $27.5M | Buy |
323,852
+23,139
| +8% | +$1.97M | 0.03% | 582 |
|
2017
Q2 | $22.8M | Buy |
300,713
+37,500
| +14% | +$2.84M | 0.03% | 612 |
|
2017
Q1 | $17.4M | Sell |
263,213
-41,596
| -14% | -$2.75M | 0.03% | 713 |
|
2016
Q4 | $19.3M | Buy |
304,809
+19,395
| +7% | +$1.23M | 0.03% | 621 |
|
2016
Q3 | $18.2M | Buy |
285,414
+28,665
| +11% | +$1.83M | 0.03% | 599 |
|
2016
Q2 | $19.1M | Sell |
256,749
-54,526
| -18% | -$4.06M | 0.03% | 559 |
|
2016
Q1 | $20.8M | Buy |
311,275
+260,051
| +508% | +$17.4M | 0.03% | 511 |
|
2015
Q4 | $3.47M | Buy |
51,224
+18,667
| +57% | +$1.26M | 0.01% | 1723 |
|
2015
Q3 | $1.74M | Buy |
32,557
+330
| +1% | +$17.6K | ﹤0.01% | 1948 |
|
2015
Q2 | $2.03M | Buy |
32,227
+4,963
| +18% | +$312K | ﹤0.01% | 2234 |
|
2015
Q1 | $1.31M | Buy |
27,264
+12,306
| +82% | +$592K | ﹤0.01% | 2578 |
|
2014
Q4 | $497K | Buy |
+14,958
| New | +$497K | ﹤0.01% | 3273 |
|
2014
Q3 | – | Sell |
-9,039
| Closed | -$351K | – | 3845 |
|
2014
Q2 | $351K | Sell |
9,039
-1,762
| -16% | -$68.4K | ﹤0.01% | 3428 |
|
2014
Q1 | $453K | Buy |
10,801
+3,374
| +45% | +$142K | ﹤0.01% | 3228 |
|
2013
Q4 | $244K | Sell |
7,427
-4,895
| -40% | -$161K | ﹤0.01% | 3524 |
|
2013
Q3 | $333K | Sell |
12,322
-17,758
| -59% | -$480K | ﹤0.01% | 3337 |
|
2013
Q2 | $702K | Buy |
+30,080
| New | +$702K | ﹤0.01% | 2711 |
|